3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Classical hematology
1
Conditions
Leukemia, Myeloid, Acute
22
Leukemia
21
Precursor Cell Lymphoblastic Leukemia-Lymphoma
18
Myelodysplastic Syndromes
17
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
12
Lymphoma
11
Leukemia, Lymphocytic, Chronic, B-Cell
8
Lymphoma, Non-Hodgkin
6
Multiple Myeloma
5
Leukemia, Biphenotypic, Acute
5
Hodgkin Disease
5
Hematologic Neoplasms
5
Hematologic Diseases
5
Graft vs Host Disease
4
Myeloproliferative Disorders
3
Lymphoma, Follicular
3
Leukemia, Myeloid
3
Leukemia, Lymphoid
3
Congenital Abnormalities
3
Burkitt Lymphoma
3
Waldenstrom Macroglobulinemia
2
Preleukemia
2
Precancerous Conditions
2
Neoplasms, Plasma Cell
2
Neoplasms by Histologic Type
2
Neoplasms
2
Lymphoproliferative Disorders
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, B-Cell, Marginal Zone
2
Lymphatic Diseases
2
Interventions
Cyclophosphamide
19
fludarabine phosphate
18
Whole-Body Irradiation
16
Melphalan
15
fludarabine
13
Tacrolimus
13
Busulfan
13
Peripheral Blood Stem Cell Transplantation
11
Mycophenolic Acid
11
Antilymphocyte Serum
6
Alemtuzumab
6
Methotrexate
5
Cyclosporine
5
Stem Cell Transplantation
4
thymoglobulin
3
Thiotepa
3
Methylprednisolone
3
Granulocyte Colony-Stimulating Factor
3
Etoposide
3
AP 1903 reagent
3
Transplantation
2
Sirolimus
2
Rituximab
2
Immunoenzyme Techniques
2
Hematopoietic Stem Cell Transplantation
2
Flow Cytometry
2
Filgrastim
2
Cord Blood Stem Cell Transplantation
2
visilizumab
1
sargramostim
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Anemia, Aplastic
×
Bone Marrow Transplantation
×
Other hematologic neoplasm
×
Clear all
NCT07145411
2025-08-28
HOPE
Ossium Health, Inc.
Recruiting
10 enrolled